デフォルト表紙
市場調査レポート
商品コード
1473932

マイクロバブル/超音波造影剤の世界市場規模、シェア、成長分析、疾患領域別、用途別-産業予測、2024~2031年

Global Microbubbles/Ultrasound Contrast Agents Market Size, Share, Growth Analysis, By Disease Area(cardiovascular diseases, renal diseases), By Application(molecular imaging, drug delivery) - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
マイクロバブル/超音波造影剤の世界市場規模、シェア、成長分析、疾患領域別、用途別-産業予測、2024~2031年
出版日: 2024年04月28日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

マイクロバブル/超音波造影剤の世界市場規模は、2022年に18億7,000万米ドルと評価され、2023年の19億4,000万米ドルから2031年には26億6,000万米ドルに成長し、予測期間中(2024~2031年)にCAGR 4.00%で成長する展望です。

X線下の液体や構造物の可視性を高めるために医用画像診断で使用される物質は、造影剤または造影媒体として知られ、通常X線に対して透明です。造影超音波イメージングでは、マイクロバブルは放射線学と心臓病学で血液プール剤として機能し、遺伝子治療、ドラッグデリバリー、分子イメージング、幹細胞デリバリーで広範な応用を見出しています。これらのマイクロバブルは、疾患特異的な分子マーカーと結合することによっても機能し、標的診断の手段を記載しています。マイクロバブルは、静脈注射によって循環する赤血球のような働きをし、超音波パルスの下で強いエコーを発生させ、周囲の軟組織ガスとは異なるエコー源性によって超音波の反射や後方散乱を増幅し、心エコー図にコントラストを与えます。

目次

エグゼクティブサマリー

  • 市場概要
  • 隆盛と衰退

調査手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模の推定
  • 市場の危機と限界

親市場の分析

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題

主要市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリクス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主要投資の分析
  • 主要成功要因
  • 競合の程度

市場力学と展望

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制情勢
  • ポーターの分析
  • 将来の混乱についての特別な考察

マイクロバブル/超音波造影剤の世界市場:疾患領域別

  • 市場概要
  • 心血管疾患
  • 腎臓疾患
  • その他

マイクロバブル/超音波造影剤の世界市場:用途別

  • 市場概要
  • 分子イメージング
  • ドラッグデリバリー
  • 遺伝子治療
  • 幹細胞デリバリー

マイクロバブル/超音波造影剤の世界市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他の欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他のラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他の中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主要市場企業が採用した戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • General Electric Company
  • Bracco Imaging S.p.A.
  • Lantheus Holdings, Inc.
  • Daiichi Sankyo Company, Limited
  • Bayer AG
  • Fujifilm Holdings Corporation
  • Sanofi S.A.
  • Siemens Healthineers AG
  • Guerbet Group
  • nanoPET Pharma GmbH
  • MBI Co., Ltd.
  • Trivitron Healthcare
  • Unilife Corporation
  • PTW Freiburg GmbH
  • Esaote SpA
  • Mindray Medical International Limited
  • Samsung Electronics Co., Ltd.
  • Shimadzu Corporation
  • Philips Healthcare
  • Canon Medical Systems Corporation
目次
Product Code: SQMIG35H2055

Global Microbubbles/Ultrasound Contrast Agents Market size was valued at USD 1.87 billion in 2022 and is poised to grow from USD 1.94 billion in 2023 to USD 2.66 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).

A substance used in medical imaging to enhance the visibility of fluids or structures under X-rays, known as contrast media or contrast agent, is typically transparent to X-rays. In contrast ultrasound imaging, microbubbles serve as a blood pool agent in radiology and cardiology, finding extensive application in gene therapy, drug delivery, molecular imaging, and stem cell delivery. These microbubbles can also operate by binding to disease-specific molecular markers, offering a means of targeted diagnosis. Functioning akin to red blood cells in circulation upon intravenous injection, microbubbles generate strong echoes under ultrasound pulses, providing enhanced contrast in echocardiograms by amplifying ultrasound reflection or backscattering due to their differing echogenicity from surrounding soft tissue gases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbubbles/Ultrasound Contrast Agents Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbubbles/Ultrasound Contrast Agents Market Segmental Analysis

Microbubbles/Ultrasound Contrast Agents market is segmented on the basis of disease area, By application, and By Region. Whereas, Disease area is sub segmented into cardiovascular diseases, renal diseases, and others. By Application is sub segmented into the molecular imaging, drug delivery, gene therapy, and stem cells delivery. By Region is segmented on the basis of North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.

Drivers of the Global Microbubbles/Ultrasound Contrast Agents Market

The utilization of microbubbles and ultrasound contrast agents in molecular imaging is increasingly fueled by the rising requirement for targeted therapies and the necessity to monitor biomarker status in vascular endothelium. Over the projected period, the market for microbubbles/ultrasound contrast agents is expected to grow, propelled by advancements in ultrasound technologies, escalating demand for targeted diagnostic instruments, the inherent advantages of microbubbles/ultrasound contrast agents compared to conventional diagnostic methods, and a surge in chronic disease prevalence.

Restraints in the Global Microbubbles/Ultrasound Contrast Agents Market

The global Microbubbles/Ultrasound Contrast Agents market faces a significant restraint due to the brief lifespan of microbubbles, hindering its growth prospects throughout the forecast period. Additionally, regulatory hurdles, limited reimbursement policies, and high manufacturing costs further impede market expansion, posing challenges to widespread adoption and innovation in ultrasound contrast agents.

Market Trends of the Global Microbubbles/Ultrasound Contrast Agents Market

In the fields of cardiology and radiology, microbubbles are employed as blood-pool agents in contrast ultrasound imaging but are increasingly acknowledged for their promise as targeted agents in molecular imaging. By incorporating ligand molecules that attach to disease-specific molecular markers, microbubbles can be tailored for functionality. This enables the monitoring of biomarker status in vascular endothelium, visualization of tumor vasculature, and imaging of inflammation, ischemia-reperfusion injury zones, and thrombi, presenting diverse clinical applications for molecular imaging utilizing microbubble-based ultrasound contrast agents.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Microbubbles/Ultrasound Contrast Agents Market by Disease Area

  • Market Overview
  • cardiovascular diseases
  • renal diseases
  • and others

Global Microbubbles/Ultrasound Contrast Agents Market by Application

  • Market Overview
  • molecular imaging
  • drug delivery
  • gene therapy
  • and stem cells delivery

Global Microbubbles/Ultrasound Contrast Agents Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • General Electric Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bracco Imaging S.p.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lantheus Holdings, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Daiichi Sankyo Company, Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Holdings Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Guerbet Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • nanoPET Pharma GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MBI Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trivitron Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Unilife Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PTW Freiburg GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Esaote SpA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mindray Medical International Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Samsung Electronics Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Canon Medical Systems Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments